Discover
CPRX
Catalyst Pharmaceuticals, Inc.
31.44
13 x 31.43
1 x 35.86
bid
ask
+
0.01
0.03%
7 @ 04:00 PM
31.30 -0.14 (0.45%)
| Ytd | 34.70% | |
| 1y | 48.37% |
31.43
day range
31.46
19.05
52 week range
32.56
| Open | 31.45 | Prev Close | 31.43 | Low | 31.43 | High | 31.46 | Mkt Cap | 3.85B |
| Vol | 783.44K | Avg Vol | 2.33M | EPS | 1.73 | P/E | 18.17 | Forward P/E | 9.88 |
| Beta | 0.74 | Short Ratio | 3.99 | Inst. Own | 89.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 30.61 | 200-d Avg | 24.89 | 1yr Est | 31.67 |
CPRX News
globenewswire.com
Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characterist
Data Demonstrate Vamorolone's Balanced Corticosteroid Profile with On-Target Glucocorticoid Activity
gurufocus.com
Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders?
Are NUVL, CPRX, TMHC Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 202